Skip to content
Catalyst

PapersPMID:40647269

Twelve-Week Curcumin Supplementation Improves Glucose Homeostasis and Gut Health in Prediabetic Older Adults: A Pilot, Double-Blind, Placebo-Controlled Trial.

Nutrients2025The record ↗

  1. Finding, moderate evidenceno difference foundFasting blood glucose

No finding here moved its endpoint.

What did not

1 findingHow to read these marks →
  • “In contrast, the fasting blood glucose levels remained the same in both the curcumin ( p = 0.154, 95% CI: −7.547 to 0.976) and placebo group ( p > 0.999, 95% CI: −5.537 to 5.093).”
    Study
    RCT
    Duration
    3 months
    Dose studied
    80 mg curcumin (Longvida lipophilic matrix), one capsule daily
    Population
    adults aged 60 years or older with prediabetes or overweight/obesity; co-primary endpoint

Study record

Design
randomised controlled trial
Species
human
Population
Older adults (60 years or older) with prediabetes or overweight/obesity; curcumin 80 mg capsules
Participants
28
Comparator
placebo
Duration
84 days
Endpoints measured
7
Declined
another reason, stated per paper